Potential of mucoadhesive chitosan glutamate microparticles as microbicide carriers – antiherpes activity and penetration behavior across the human vaginal epithelium

References

• Ahmed TA, Aljaeid BM. (2016). Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Des Devel Ther 10:483–507.
   PubMed Web of Science ®Google Scholar
• Ahsan SM, Thomas M, Reddy KK, et al. (2018). Chitosan as biomaterial in drug delivery and tissue engineering. Int J Biol Macromol 110:97–109.
   PubMed Web of Science ®Google Scholar
• Andersen T, Bleher S, Eide Flaten G, et al. (2015). Chitosan in mucoadhesive drug delivery: focus on local vaginal therapy. Mar Drugs 13:222–36.
   PubMed Web of Science ®Google Scholar
• AVAC. (2021). Global advocacy on HIV preventions. Microbicide candidates are in the early phases of development. Available at: https://www.avac.org/trial-summary-table/microbicides [last assessed 20 Jun 2021].
   Google Scholar
• Bagdonaite I, Nordén R, Joshi HJ, et al. (2015). A strategy for O-glycoproteomics of enveloped viruses-the O-glycoproteome of herpes simplex virus type 1. PLoS Pathog 11:e1004784.
   PubMed Web of Science ®Google Scholar
• Balasch-Risueño J, López M. (inventors). (2019). Gel compriding chlorhexidine. World Intellectual Property Organization WO2019/025599Al; PCT/EP2018/071155, 2019.02.07.
   Google Scholar
• Bernkop-Schnürch A, Hornof M. (2003). Intravaginal drug delivery systems. Design, challenges, and solutions. Am J Drug Deliv 1:241–54.
   Google Scholar
• Caramella C, Ferrari F, Bonferoni MC, et al. (2010). Chitosan and its derivatives as drug penetration enhancers. J Drug Deliv Sci Technol 20:5–13.
   Web of Science ®Google Scholar
• Chowdhury S, Naderi M, Chouljenko VN, et al. (2012). Amino acid differences in glycoproteins B (gB), C (gC), H (gH) and L (gL) are associated with enhanced herpes simplex virus type-1 (McKrae) entry via the paired immunoglobulin-like type-2 receptor α. Virol J 9:112–20.
   PubMed Web of Science ®Google Scholar
• Clinical Trials. (2021). Clinical trials: safety and effectiveness of tenofovir gel in the prevention of human immunodeficiency virus (HIV-1) infection in women and the effects of tenofovir gel on the incidence of herpes simplex virus (HSV-2) infection. Available at: https://clinicaltrials.gov/ct2/show/NCT01386294 [last assessed 15 Jun 2021].
   Google Scholar
• Cordis. (2021). Community Research and Development Information Service. Available at: https://cordis.europa.eu/result/rcn/57008_en.html [last assessed 15 Jun 2021].
   Google Scholar
• Czechowska-Biskup R, Jarosińska D, Rokita B, et al. (2012). Determination degree of deacetylation of chitosan: comparison of methods. Prog Chem Appl Chitin Deriv 17:5–20.
   Google Scholar
• Dott C, Tyagi C, Tomar LK, et al. (2013). Mucoadhesive electrospun nanofibrous matrix for rapid oramucosal drug delivery. J Nanomater 2013:1–19.
   Web of Science ®Google Scholar
• Dunge A, Sharda N, Singh B, Singh S. (2005). Validated specific HPLC method for determination of zidovudine during stability studies. J Pharm Biomed Anal 37:1109–14.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. (2021). Draft guideline on quality and equivalence of topical products. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-quality-equivalence-topical-products_en.pdf [last assessed 24 Jun 2021].
   Google Scholar
• Frank LA, Chaves PS, D'Amore CM, et al. (2017). The use of chitosan as cationic coating or gel vehicle for polymeric nanocapsules: increasing penetration and adhesion of imiquimod in vaginal tissue. Eur J Pharm Biopharm 114:202–12.
   PubMed Web of Science ®Google Scholar
• Frank LA, Sandri G, D'Autilia F, et al. (2014). Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery. Int J Nanomedicine 9:3151–61.
   PubMed Web of Science ®Google Scholar
• Frum Y, Khan GM, Sefcik J, et al. (2007). Towards a correlation between drug properties and in vitro transdermal flux variability. Int J Pharm 336:140–7.
   PubMed Web of Science ®Google Scholar
• Godin B, Touitou E. (2007). Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 59:1152–61.
   PubMed Web of Science ®Google Scholar
• Godley MJ. (1985). Quantitation of vaginal discharge in healthy volunteers. Br J Obstet Gynaecol 92:739–42.
   PubMedGoogle Scholar
• Gupta R, Warren T, Wald A. (2007). Genital herpes. Lancet 370:2127–37.
   PubMed Web of Science ®Google Scholar
• He X, Xing R, Liu S, et al. (2021). The improved antiviral activities of amino-modified chitosan derivatives on Newcastle virus. Drug Chem Toxicol 44:335–40.
   PubMed Web of Science ®Google Scholar
• He Y, Niu X, Wang B, et al. (2020). Evaluation of the inhibitory effects of Lactobacillus gasseri and Lactobacillus crispatus on the adhesion of seven common lower genital tract infection-causing pathogens to vaginal epithelial cells. Front Med 7:284–92.
   Web of Science ®Google Scholar
• Karim SA, Karim QA. (2007). Diverse approaches useful for microbicide trials. Nature 449:24.
   Web of Science ®Google Scholar
• Loutfy SA, Elberry MH, Farroh KY, et al. (2020). Antiviral activity of chitosan nanoparticles encapsulating curcumin against hepatitis C virus genotype 4a in human hepatoma cell lines. Int J Nanomedicine 15:2699–715.
   PubMed Web of Science ®Google Scholar
• McQuillan G, Kruszon-Moran D, Flagg EW, Paulose-Ram R. (2018). Prevalence of herpes simplex virus type 1 and type 2 in persons aged 14–49: United States, 2015–2016. NCHS Data Brief 304:1–8.
   Google Scholar
• Meng J, Sturgis TF, Youan B-BC. (2011). Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion. Eur J Pharm Sci 44:57–67.
   PubMed Web of Science ®Google Scholar
• Merbah M, Introini A, Fitzgerald W, et al. (2011). Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection. Am J Reprod Immunol 65:268–78.
   PubMed Web of Science ®Google Scholar
• Mesquita L, Galante J, Nunes R, et al. (2019). Pharmaceutical vehicles for vaginal and rectal administration of anti-HIV microbicide nanosystems. Pharmaceutics 11:145–65.
   PubMed Web of Science ®Google Scholar
• Michaelis M, Kleinschmidt MC, Bojkova D, et al. (2019). Omeprazole increases the efficacy of acyclovir against herpes simplex virus type 1 and 2. Front Microbiol 10:2790–7.
   PubMed Web of Science ®Google Scholar
• Namvar L, Olofsson S, Bergström T, Lindh M. (2005). Detection and typing of herpes simplex virus in mucocutaneous samples by TaqMan PCR targeting a gB segment homologous for HSV types 1 and 2. J Clin Microbiol 43:2058–64.
   PubMed Web of Science ®Google Scholar
• Orlowski P, Tomaszewska E, Gniadek M, et al. (2014). Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection. PLoS One 9:e104113.
   PubMed Web of Science ®Google Scholar
• Owen DH, Katz DF. (1999). A vaginal fluid simulant. Contraception 59:91–5.
   PubMed Web of Science ®Google Scholar
• Patel SK, Rohan LC. (2017). On-demand microbicide products: design matters. Drug Deliv Transl Res 7:775–95.
   PubMed Web of Science ®Google Scholar
• Potaś J, Szymańska E, Basa A, et al. (2020). Tragacanth gum/chitosan polyelectrolyte complexes-based hydrogels enriched with xanthan gum as promising materials for buccal application. Materials 14:86–101.
   PubMed Web of Science ®Google Scholar
• Russo E, Gaglianone N, Baldassari S, et al. (2014). Preparation, characterization and in vitro antiviral activity evaluation of foscarnet-chitosan nanoparticles. Colloids Surf B Biointerfaces 118:117–25.
   PubMed Web of Science ®Google Scholar
• Safarzadeh M, Sadeghi S, Azizi M, et al. (2021). Chitin and chitosan as tools to combat COVID-19: a triple approach. Int J Biol Macromol 183:235–44.
   PubMed Web of Science ®Google Scholar
• Sandri G, Rossi S, Ferrari F, et al. (2004). Assessment of chitosan derivatives as buccal and vaginal penetration enhancers. Eur J Pharm Sci 21:351–9.
   PubMed Web of Science ®Google Scholar
• Sauerbrei A, Deinhardt S, Zell R, Wutzler P. (2010). Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus. Antiviral Res 86:246–52.
   PubMed Web of Science ®Google Scholar
• Sauerbrei A. (2016). Optimal management of genital herpes: current perspectives. Infect Drug Resist 9:129–41.
   PubMed Web of Science ®Google Scholar
• Seña AC, Bachman L, Johnston C, et al. (2020). Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction. Lancet Infect Dis 20:181–91.
   Web of Science ®Google Scholar
• Shannon CL, Klausner JD. (2018). The growing epidemic of sexually transmitted infections in adolescents: a neglected population. Curr Opin Pediatr 30:137–43.
   PubMed Web of Science ®Google Scholar
• Sonaje K, Chuang E-Y, Lin KJ, et al. (2012). Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations. Mol Pharm 9:1271–9.
   PubMed Web of Science ®Google Scholar
• Swarbrick J. (2007). Encyclopedia of pharmaceutical technology. 3rd ed. New York: Informa Healthcare.
   Google Scholar
• Sweetman SC. (2011). Martindale: the complete drug reference. 37th ed. London: Pharma Press.
   Google Scholar
• Szymanska E, Czarnomysy R, Jacyna J, et al. (2019). Could spray-dried microbeads with chitosan glutamate be considered as promising vaginal microbicide carriers? The effect of process variables on the in vitro functional and physicochemical characteristics. Int J Pharm 568:118558.
   PubMedGoogle Scholar
• Szymańska E, Orłowski P, Winnicka K, et al. (2018). Multifunctional tannic acid/silver nanoparticle-based mucoadhesive hydrogel for improved local treatment of HSV infection: in vitro and in vivo studies. Int J Mol Sci 19:387.
   PubMed Web of Science ®Google Scholar
• Szymańska E, Winnicka K, Wieczorek P, et al. (2014). Influence of unmodified and β-glycerophosphate cross-linked chitosan on anti-Candida activity of clotrimazole in semi-solid delivery systems. Int J Mol Sci 15:17765–77.
   PubMed Web of Science ®Google Scholar
• Tien D, Schnaare RL, Kang F, et al. (2005). In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. AIDS Res Hum Retroviruses 21:845–53.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2021). Global health sector strategy on sexually transmitted infections 2016–2021. Available at: www.who.int/reproductivehealth [last assessed 20 Jun 2021].
   Google Scholar
• Zhang Y, Chan HF, Leong KW. (2013). Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev 65:104–20.
   PubMed Web of Science ®Google Scholar